Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector
about
Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cellsPhase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansExpression and V(D)J recombination activity of mutated RAG-1 proteinsA broad spectrum secreted chemokine binding protein encoded by a herpesvirusp38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2.Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor ageInterleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PMLReactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassetteMorbillivirus downregulation of CD46.An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus.Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest responseCD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamilyCombined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization.The mouse B cell-specific mb-1 gene encodes an immunoreceptor tyrosine-based activation motif (ITAM) protein that may be evolutionarily conserved in diverse species by purifying selection.Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.SUMO-1 modification of human cytomegalovirus IE1/IE72Regulation of vascular smooth muscle cell proliferation, migration and death by heparan sulfate 6-O-endosulfatase1.Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression.Intercellular calcium waves in HeLa cells expressing GFP-labeled connexin 43, 32, or 26Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brain.The promise of gene therapy in gastrointestinal and liver diseases.Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chOverexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE(-/-) mouse model.Adenovirus mediated intra-articular expression of collagenase-3 (MMP-13) induces inflammatory arthritis in mice.Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cellsUtilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins.Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function.Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cellsLocalization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast.Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil
P2860
Q28165527-F6176636-24B3-4351-B28E-671BD8E8B5F3Q28482937-4553BE26-7732-455F-8346-BEA12400EFE5Q28506727-DCE32935-1821-4ADE-9874-95A06180E311Q30326102-F84CCD20-653D-43D8-BFF0-B6F81914F64BQ30453552-DB7772B0-2A99-4D9E-9E71-5355865D3F1AQ31112275-BCC4589B-6A1C-4443-BD3D-61CD2264912CQ33228402-B2EC4A18-937E-42BE-8731-9AD82FA9A03AQ33556402-0DF85D0F-18C1-4D00-AC62-767CA2C41789Q33748410-956908CD-A2C9-4C83-A797-30123555E5D9Q33776312-C3931A58-9B00-4E2F-8E3E-65DE7265C87AQ33781921-82B21DC8-835D-4361-B8BD-15A1628C410AQ33782466-209D5BC1-A624-487A-90A5-14B36E2A24B9Q33786395-64C858A8-C096-4237-8335-56DFDE6484ECQ33904045-145D3550-9ACC-46FC-B642-27BE085477AFQ33930511-4236B469-A785-44A0-ACD6-4C40FBA2C707Q33964729-60D62E59-6DCA-494D-9168-172D6FC26095Q34063140-077BBE32-A905-4113-90B4-26917D4BEF83Q34132949-FB49D719-EC15-4F66-8826-D534735BC959Q34193922-40FC2A64-201A-429F-ADB9-BB9671EB1D80Q34200369-515D80B9-B0C4-402A-9484-816A32F1A69DQ34332305-D04D30ED-71E4-40A2-A525-BBE3604D26B0Q34467837-6B9E6CAE-4626-4AEA-9937-5BA5584A09A2Q34546483-2C2BF02D-E61C-4D0F-BC37-7B9B3B38F3D4Q34714675-EA8F17A0-A633-4A84-B37C-448FA9EB1009Q35069546-458BAB26-490A-4BFB-8F71-CC9651239545Q35090229-BBFDC63C-0F5C-4793-88C1-A1884FC1E1CBQ35161530-669D1B9F-65F6-4938-A2FE-E10CB680468EQ35502017-0A1A0441-F628-4F5F-A9DB-BA5A827C61CBQ35554174-8D5F9860-78B2-45C7-B846-58A9F7A73596Q35656213-0EC75951-3170-4CAF-A41A-367A123C4665Q35828380-74CA5617-569A-49BA-B813-C1C47EF3F2C0Q35876228-00ACEDF2-EDE1-4125-8FD4-C84A1E93B006Q35881379-7D0EA666-C818-4BC5-9E4A-D27352F07909Q35886859-1705251F-127C-4E53-BBAE-033623531515Q35894775-275E2646-6959-4192-844C-EE6B06B130A6Q35948480-D43AE987-7FAE-44F6-AE8F-12B34D250AF1Q36274402-E2D3BF7B-76FA-4A59-A907-1A98817FDF96Q36371913-05AEF505-23A9-4F35-A755-99CFBE599075Q36503490-FCFBA156-D380-40DD-BE61-1DDFEAAB37B6Q36671725-8782E006-79EC-47CB-A35C-020E811B2006
P2860
Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Constitutive and enhanced expr ...... a defective adenovirus vector
@ast
Constitutive and enhanced expr ...... a defective adenovirus vector
@en
type
label
Constitutive and enhanced expr ...... a defective adenovirus vector
@ast
Constitutive and enhanced expr ...... a defective adenovirus vector
@en
prefLabel
Constitutive and enhanced expr ...... a defective adenovirus vector
@ast
Constitutive and enhanced expr ...... a defective adenovirus vector
@en
P2860
P356
P1476
Constitutive and enhanced expr ...... a defective adenovirus vector
@en
P2093
Wilkinson GW
P2860
P304
P356
10.1093/NAR/20.9.2233
P407
P577
1992-05-01T00:00:00Z